Labcorp Holdings Inc. LH, or Labcorp, is well-poised to grow in the coming quarters due to its strong, consistent performance in high-growth areas. In recent years, the company has built a significant ...

Labcorp Holdings Inc. LH, or Labcorp, is well-poised to grow in the coming quarters, courtesy of its Biopharma Laboratory Services (“BLS”) segment’s robust growth. A strong focus on operational ...

Investors might want to bet on Labcorp Holdings (LH), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of ...

Labcorp Holdings LH, or Labcorp, reported adjusted earnings per share (EPS) of $4.35 for the second quarter of 2025. The figure rose 10.4% from the year-ago level. The adjusted figure excludes the ...

Labcorp Holdings has rallied 27% on multiple expansion, but growth prospects remain moderate and capital intensity is rising. Q2 results showed solid revenue and margin gains, with raised guidance, ...

Laboratory Corp (NYSE: LH) on Thursday reported second-quarter 2025 adjusted earnings per share of $4.35, up from $3.94 a year ago, beating the consensus of $4.17. Sales increased 9.5% year-over-year ...

BURLINGTON, N.C., May 28, 2024 /PRNewswire/ -- Labcorp (LH) (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that members of the executive management ...

Principal Financial Group Inc. grew its position in Labcorp Holdings Inc. (NYSE:LH – Free Report) by 0.4% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 95,004 ...